advertisement
Tsang SH 65
Showing records 1 to 25 | Display all abstracts from Tsang SH106602 CRISPR Manipulations in Stem Cell Lines
Chang YJ
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 249-256
105760 Therapeutic Gene Editing in Inherited Retinal Disorders
Ling J
Cold Spring Harbor perspectives in medicine 2023; 13:
106599 Ophthalmic Fluorescein Angiography
Baddam DO
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 153-160
106109 A pathogenic in-frame deletion-insertion variant in BEST1 phenocopies Stargardt disease
Kolesnikova M
JCI insight 2022; 7:
106604 CRISPR-Mediated Genome Engineering in Cell Lines
Chang YJ
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 267-278
106606 Prime Editing for the Installation and Correction of Mutations Causing Inherited Retinal Disease: A Brief Methodology
Tsai YT
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 313-331
106375 RNA-based therapies in inherited retinal diseases
Girach A
Therapeutic advances in ophthalmology 2022; 14: 25158414221134602
106603 Metabolite Extraction from RPE Cells and Retinas Related to Retinitis Pigmentosa
Cui X
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 257-265
106030 Chorioretinal atrophy following voretigene neparvovec despite the presence of fundus autofluorescence
Kolesnikova M
Molecular genetics & genomic medicine 2022; 10: e2038
106600 Protocol for Indocyanine Green Angiography
Baddam DO
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 161-167
106601 Autofluorescence Imaging to Evaluate Retinal Disease Progression in Rodent
Cheng CH
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 229-232
106109 A pathogenic in-frame deletion-insertion variant in BEST1 phenocopies Stargardt disease
Oh JK
JCI insight 2022; 7:
106603 Metabolite Extraction from RPE Cells and Retinas Related to Retinitis Pigmentosa
Chang YJ
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 257-265
106604 CRISPR-Mediated Genome Engineering in Cell Lines
Ryu J
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 267-278
106375 RNA-based therapies in inherited retinal diseases
Audo I
Therapeutic advances in ophthalmology 2022; 14: 25158414221134602
106030 Chorioretinal atrophy following voretigene neparvovec despite the presence of fundus autofluorescence
Lima de Carvalho JR
Molecular genetics & genomic medicine 2022; 10: e2038
106600 Protocol for Indocyanine Green Angiography
Ragi SD
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 161-167
106601 Autofluorescence Imaging to Evaluate Retinal Disease Progression in Rodent
Cui X
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 229-232
106602 CRISPR Manipulations in Stem Cell Lines
Cui X
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 249-256
106599 Ophthalmic Fluorescein Angiography
Ragi SD
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 153-160
106606 Prime Editing for the Installation and Correction of Mutations Causing Inherited Retinal Disease: A Brief Methodology
da Costa BL
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 313-331
105760 Therapeutic Gene Editing in Inherited Retinal Disorders
Jenny LA
Cold Spring Harbor perspectives in medicine 2023; 13:
106375 RNA-based therapies in inherited retinal diseases
Birch DG
Therapeutic advances in ophthalmology 2022; 14: 25158414221134602
106599 Ophthalmic Fluorescein Angiography
Tsang SH
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 153-160
106606 Prime Editing for the Installation and Correction of Mutations Causing Inherited Retinal Disease: A Brief Methodology
Nolan ND
Methods in molecular biology (Clifton, N.J.) 2023; 2560: 313-331
